Answers are grounded in this paper and cite their sources.
Consistent with the results in the overall population, dupilumab reduced the risk of severe asthma exacerbations and improved lung function in Latin American patients with uncontrolled, moderate-to-severe asthma and a type 2 phenotype.
No takes yet. Share an insight, caveat, or question.
Máspero et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: